Latest Strategy Changes News

Cochlear Limited has updated its dividend details, confirming a fully franked ordinary dividend of AUD 2.15 per share for the first half of 2025, with payments available in multiple currencies based on shareholder location.

PYC Therapeutics has restructured its Board and executive team to steer the company through pivotal clinical milestones expected by the end of 2027. The changes signal a strategic push toward late-stage development of its RNA-based drug candidates.

HealthCo Healthcare & Wellness REIT has collected all outstanding rent from Healthscope and extended a rent deferral to support the ongoing sale process, while suspending distributions to preserve liquidity.

LTR Pharma has acquired a one-third equity stake in LevOmega Pty Ltd at no cost to shareholders, positioning itself in the growing pharmaceutical-grade omega-3 sector. This strategic move complements LTR’s existing intranasal pharmaceutical portfolio and aligns with its innovation-driven growth strategy.

Estrella Resources has reported substantial high-grade supergene manganese intersections at its Ira Miri project in Timor-Leste, highlighting promising mineralisation near key infrastructure. Assay results are pending, but early visual estimates suggest significant resource potential.

Broken Hill Mines reports impressive high-grade silver, lead, zinc, gold, and copper intercepts from its FY26 drilling at Pinnacles Mine, setting the stage for a resource upgrade and potential mine restart.

Vault Minerals projects steady gold production in FY26 with growth through FY28, driven by key plant upgrades and the anticipated restart of Sugar Zone operations. The company plans significant capital and exploration investments while preparing to fully unwind its hedge book.

Auric Mining is poised to kick off its first toll milling campaign at Black Cat’s Lakewood Mill in late October, aiming to generate initial gold revenue by November from its Munda Starter Pit.

EVE Health Group has begun distributing Dyspro™, a novel cannabinoid-based treatment for dysmenorrhoea and endometriosis, through a national telehealth partnership. This launch targets a significant unmet need in women’s health with a growing global market.

Ardea Resources has completed a major infill drilling campaign at its Goongarrie South deposit, confirming premium nickel-cobalt-scandium mineralisation that underpins its Definitive Feasibility Study. The results reinforce the project’s position as Australia’s largest nickel-cobalt resource.

ChemX Materials Limited has entered voluntary administration following a turbulent quarter marked by convertible note amendments, a trading suspension, and ongoing funding challenges.

XPON Technologies announces a significant leadership reshuffle with founder Matt Forman stepping down as CEO due to health reasons, while Mark Simari assumes the role of Executive Chair amid strategic growth initiatives.